1. A case of autoimmune myositis after treatment with alemtuzumab for multiple sclerosis. Issue 4 (December 2018) Authors: Aouad, Patrick; Yiannikas, Con; Fernando, Suran L; Parratt, John Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 4:Issue 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A case of presumed herpes keratouveitis in a patient treated with fingolimod. (3rd June 2016) Authors: Ayers, Malissa C; Conway, Devon S Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A comparative study of tolerability and effects on immunoglobulin levels and CD19 cell counts with ocrelizumab vs low dose of rituximab in multiple sclerosis. Issue 4 (September 2020) Authors: Evertsson, Björn; Hoyt, Tammy; Christensen, Angel; Nimer, Faiez AL; Foley, John; Piehl, Fredrik Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 6:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A comparison of multiple sclerosis disease activity after discontinuation of fingolimod and placebo. Issue 3 (September 2017) Authors: Vermersch, Patrick; Radue, Ernst-Wilhelm; Putzki, Norman; Ritter, Shannon; Merschhemke, Martin; Freedman, Mark S Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 3:Issue 3(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A composite measure to explore visual disability in primary progressive multiple sclerosis. Issue 2 (May 2017) Authors: Poretto, Valentina; Petracca, Maria; Saiote, Catarina; Mormina, Enricomaria; Howard, Jonathan; Miller, Aaron; Lublin, Fred D; Inglese, Matilde Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 3:Issue 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis. Issue 4 (November 2017) Authors: Eisen, Andrew; Greenberg, Benjamin M; Bowen, James D; Arnold, Douglas L; Caggiano, Anthony O Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 3:Issue 4(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclerosis immediately following a relapse. Issue 2 (April 2022) Authors: Greenberg, Benjamin M.; Bowen, James D.; Alvarez, Enrique; Rodriguez, Moses; Caggiano, Anthony O.; Warrington, Arthur E.; Zhao, Ping; Eisen, Andrew Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 8:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A feasibility study of a manualized resilience-based telehealth program for persons with multiple sclerosis and their support partners. Issue 3 (August 2020) Authors: Halstead, Elizabeth J; Leavitt, Victoria M; Fiore, Damian; Mueser, Kim T Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 6:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A group-delivered self-management program reduces spasticity in people with multiple sclerosis: A randomized, controlled pilot trial. Issue 1 (March 2017) Authors: Hugos, Cinda L; Bourdette, Dennis; Chen, Yiyi; Chen, Zunqiu; Cameron, Michelle Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 3:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A multisite randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Very long term (5–6 year) follow-up at one site. Issue 4 (October 2021) Authors: Norton, Julia; Joos, Sandra; Cameron, Michelle H; Hugos, Cinda L Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 7:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗